Rajender R Aparasu (Holly M Holmes, Rajender Aparasu)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Venues

Drugs & aging

Pharmacotherapy

Pain medicine (Malden, Mass.)

International journal of geriatric psychiatry

University of Houston

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Houston

United States

Professor and Chair :: Department of Pharmaceutical Health Outcomes and Policy

South Dakota State University

United States

Professor :: College of Pharmacy

Publications

Ashna Talwar, Satabdi Chatterjee, Susan Abughosh, Michael Johnson, Jeffrey Sherer, Rajender R Aparasu
Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time-series analysis of Medicare data. Pharmacotherapy (2024)
Ashna Talwar, Satabdi Chatterjee, Jeffrey Sherer, Susan Abughosh, Michael Johnson, Rajender R Aparasu
Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer's Disease Initiating Cholinesterase Inhibitors. Drugs & aging 41 (4) (2024)
Ashna Talwar, Satabdi Chatterjee, Jeffrey Sherer, Susan Abughosh, Michael Johnson, Rajender R Aparasu
Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer's Disease Initiating Cholinesterase Inhibitors. Drugs & aging (2024)
Ashna Talwar, Satabdi Chatterjee, Jeffrey Sherer, Susan Abughosh, Michael Johnson, Rajender R Aparasu
Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer's Disease Initiating Cholinesterase Inhibitors. Drugs & aging 41 (4) (2024)
Yinan Huang, Sandeep K Agarwal, Satabdi Chatterjee, Hua Chen, Michael L Johnson, Rajender R Aparasu
Risk of incident cardiovascular events with disease-modifying anti-rheumatic drugs among adults with rheumatoid arthritis: a nested case-control study. Clinical rheumatology (2023)
Jagadeswara Rao Earla, Jieni Li, George J Hutton, Michael L Johnson, Rajender R Aparasu
Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosis. Pharmacotherapy (2023)
Jagadeswara Rao Earla, Jieni Li, George J Hutton, Michael L Johnson, Rajender R Aparasu
Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosis. Pharmacotherapy (2023)
Prajakta P Masurkar, Satabdi Chatterjee, Jeffrey T Sherer, Hua Chen, Michael L Johnson, Rajender R Aparasu
Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study. Drugs & aging 39 (6) (2022)
Prajakta P Masurkar, Satabdi Chatterjee, Jeffrey T Sherer, Rajender R Aparasu
Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia. Drugs & aging 38 (7) (2021)
Satabdi Chatterjee, David Walker, Tomomi Kimura, Rajender R Aparasu
The Costs and Healthcare Resource Utilization Associated with Anticholinergic Burden in Long-Stay Nursing Home Residents with Overactive Bladder in the US. PharmacoEconomics - open 5 (4) (2021)
Yinan Huang, Ashna Talwar, Satabdi Chatterjee, Rajender R Aparasu
Application of machine learning in predicting hospital readmissions: a scoping review of the literature. BMC medical research methodology 21 (1) (2021)
Prajakta P Masurkar, Satabdi Chatterjee, Jeffrey T Sherer, Hua Chen, Michael L Johnson, Rajender R Aparasu
Risk of overactive bladder associated with cholinesterase inhibitors in dementia. Journal of the American Geriatrics Society (2021)
Yinan Huang, Sanika Rege, Satabdi Chatterjee, Rajender R Aparasu
Opioid Prescribing Among Outpatients with Rheumatoid Arthritis. Pain medicine (Malden, Mass.) 22 (10) (2021)
Sanika Rege, Ryan M Carnahan, Michael L Johnson, Hua Chen, Holly M Holmes, Rajender R Aparasu
Antipsychotic Initiation Among Older Dementia Patients Using Cholinesterase Inhibitors: A National Retrospective Cohort Study. Drugs & aging 38 (6) (2021)
Jagadeswara Rao Earla, George J Hutton, James Douglas Thornton, Hua Chen, Michael L Johnson, Rajender R Aparasu
Comparative treatment effectiveness of oral fingolimod and conventional injectable disease-modifying agents in multiple sclerosis. Pharmacotherapy 41 (5) (2021)
Jagadeswara Rao Earla, George J Hutton, James Douglas Thornton, Hua Chen, Michael L Johnson, Rajender R Aparasu
Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis. Patient preference and adherence 14 (2020)
Nandita Kachru, Holly M Holmes, Michael L Johnson, Hua Chen, Rajender R Aparasu
Comparative risk of adverse outcomes associated with nonselective and selective antimuscarinic medications in older adults with dementia and overactive bladder. International journal of geriatric psychiatry 36 (5) (2020)
Nandita Kachru, Holly M Holmes, Michael L Johnson, Hua Chen, Rajender R Aparasu
Risk of Mortality Associated with Non-selective Antimuscarinic medications in Older Adults with Dementia: a Retrospective Study. Journal of general internal medicine 35 (7) (2020)
Farid Chekani, Rajender R Aparasu, Michael L Johnson, Hua Chen, Jeffrey T Sherer, Rajender R Aparasu
Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson's Disease and Comorbid Depression. Drug, healthcare and patient safety 12 (2020)
Aylin Yucel, Swarnava Sanyal, Ekere James Essien, Osaro Mgbere, Rajender R Aparasu, Vinod S Bhatara, Joy P Alonzo, Hua Chen
Racial/ethnic differences in treatment quality among youth with primary care provider-initiated versus mental health specialist-initiated care for major depressive disorders. Child and adolescent mental health 25 (1) (2019)

Rajender R Aparasu.css-eqlu8i{font-size:small;padding-left:4px;} (Holly M Holmes, Rajender Aparasu)

Publication Activity (10 Years)

Top Topics

Top Venues

Rajender R Aparasu (Holly M Holmes, Rajender Aparasu)